MASI
HealthcareMasimo Corporation
$134.00
+$6.60 (+5.18%)
Jan 5, 2026
Price History (1Y)
Analysis
Masimo Corporation is a healthcare company specializing in medical devices. It operates within the medical devices sector and has a significant market presence, with a market capitalization of $7.20B and over 3,600 employees. The company's financial health is marked by mixed results. Its gross margin stands at 49.3%, while its operating and profit margins are lower at 21.6% and -26.1%, respectively. The negative profit margin may raise concerns about the company's ability to turn revenue into net income. On a more positive note, Masimo has generated significant free cash flow of $329.14M in the recent period, indicating its capacity to generate funds from operations. Masimo Corporation is valued at 22.71 times its trailing earnings and 35.87 times its EBITDA, which may be considered relatively high compared to other companies in its sector. The company's revenue growth rate has been steady, with a year-over-year increase of 8.2% in the recent period. However, the lack of dividend payout is notable, as the company has not distributed any dividends to its shareholders.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Masimo Corporation
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arterial oxygen saturation, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow respiratory support therapy, neuromodulation technology, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
Visit website →Key Statistics
- Market Cap
- $7.20B
- P/E Ratio
- N/A
- 52-Week High
- $194.88
- 52-Week Low
- $125.94
- Avg Volume
- 745.33K
- Beta
- 1.26
Company Info
- Industry
- Medical Devices
- Exchange
- NMS
- Country
- United States
- Employees
- 3,600